Drugs / Flumist Quadrivalent Nasal Product
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04164212 | Sep 2020 → Jan 2026 | influenza | University of Alabama at Birmingham | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Flumist Quadrivalent Nasal Product | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04164212 ↗ |
| Modality | Vaccine | “live attenuated influenza vaccine” NCT04164212 ↗ |
| Route | Intranasal | “pre-filled intranasal sprayer” NCT04164212 ↗ |